Unknown

Dataset Information

0

Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform.


ABSTRACT: Synuclein gamma (SNCG) is under consideration as a potential biomarker in cancer biology. Up to date four different SNCG variants are described. Due to growing evidence suggesting correlations between aberrant alternative splicing processes and cancer progression, we investigated the effects of peritumoural conditions on expression pattern of SNCG in endometrial cancer (EC) in vitro. Compared to breast cancer cell lines, mRNA expression levels of all known SNCG isoforms 1-4 are significantly reduced in EC cell lines. We identified a novel alternatively spliced variant of isoform 2 (isoform 2 short) which is found highly expressed in EC cell lines. Hypoxia and acidosis trigger an up-regulation of isoform 2 short. EC cell lines are characterized by low SNCG protein levels under control conditions, but exhibit a significant increase triggered by hypoxia and acidosis. In addition we analysed the potential association between SNCG protein expression and clinico-pathological parameters in human EC samples. Our findings indicate a grade-dependent induction of SNCG protein expression in endometrial cancer. We identified for the first time a novel isoform of SNCG that is found specifically expressed in EC. Our results also strongly indicate the existence of a corresponding protein of isoform 2 short that potentially plays a critical role in EC cancer progression.

SUBMITTER: Schaal K 

PROVIDER: S-EPMC4673181 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform.

Schaal Kathrin K   Hirschfeld Marc M   Bronsert Peter P   Füllgraf Hannah H   Jäger Markus M   Herde Bettina B   Nöthling Claudia C   Mayer Sebastian S   Erbes Thalia T   Stickeler Elmar E  

Oncotarget 20150901 26


Synuclein gamma (SNCG) is under consideration as a potential biomarker in cancer biology. Up to date four different SNCG variants are described. Due to growing evidence suggesting correlations between aberrant alternative splicing processes and cancer progression, we investigated the effects of peritumoural conditions on expression pattern of SNCG in endometrial cancer (EC) in vitro. Compared to breast cancer cell lines, mRNA expression levels of all known SNCG isoforms 1-4 are significantly red  ...[more]

Similar Datasets

| S-EPMC4028860 | biostudies-literature
| S-EPMC4125279 | biostudies-literature
| S-EPMC7275609 | biostudies-literature
| S-EPMC6889075 | biostudies-literature
| S-EPMC8116885 | biostudies-literature
| S-EPMC3341596 | biostudies-literature
| S-EPMC7272712 | biostudies-literature
| S-EPMC3850988 | biostudies-literature
| S-EPMC6339785 | biostudies-literature
| S-EPMC2846637 | biostudies-literature